OAKLAND COUNTY MICHIGAN'S MEDICAL MAIN STREET OFF TO GREAT START: 5 COMPANIES, $9.2 MILLION IN NEW INVESTMENT AND 240 NEW JOBS

OAKLAND COUNTY MICHIGAN'S MEDICAL MAIN STREET OFF TO GREAT START: 5 COMPANIES, $9.2 MILLION IN NEW INVESTMENT AND 240 NEW JOBS
 
WATERFORD, Mich. - Oakland County Michigan's Medical Main Street has had a great first year.  This initiative to grow the life sciences industry in Southeast Michigan has already produced some great results.  Since it's inception in September 2008, Medical Main Street has attracted the expansion of 5 life sciences companies:
 
Novixus
MicroDose Life Sciences
RG Medical Diagnostics
Oakland Genetics
Oxid Corporation
 
These companies resulted in the creation of 249 new jobs to Oakland County and an investment of over $9 million.  Oakland County Executive L. Brooks Patterson comments, "We are very excited at the progress we've made so far.  Here in Oakland County we have the workforce, we have the cheap real estate and we have some great financial incentives for companies that are looking to locate in our community."  Patterson continues, " We look forward to talking to more life sciences companies as they look to find a good North American location for their company - Oakland County, Michigan is that place."
 
In addition to company attraction, Medical Main Street also looks at helping entrepreneurs commercialize their life sciences technologies, assist local life sciences companies in growing their markets globally, continue to train the workforce for this industry, and working with state government to ensure Michigan is legislatively a top state for life sciences companies to do business in.
 
 About Oakland County Michigan's Medical Main Street:
Oakland County Michigan's Medical Main Street is a unique alliance of world-class hospitals, universities, medical device and BioPharma companies creating a global center of innovation in health care, research and development, education and commercialization in the life sciences industry.  Visit www.MedicalMainStreet.org  to get involved in the medical solutions of the future.

Suggested Articles

Chief Operating Officer Dan Paterson will lead the company while it looks for a permanent successor with commercial chops.

The job losses are part of Sanofi's pivot away from cardiovascular diseases and toward immuno-oncology drugs and gene therapies.

Parexel is looking to bolster its clinical trial work and compliance by signing a new deal with CluePoints.